Cellares is the first Integrated Development and Manufacturing Organization (IDMO) focused on revolutionizing the production of cell therapies. The company is developing and implementing advanced technologies—including the innovative Cell Shuttle platform—which integrate all necessary manufacturing processes into a flexible, high-throughput system designed for scalability and automation. This approach aims to accelerate access to vital cell therapies, enabling academics, biotechs, and pharmaceutical companies to streamline drug development, reduce costs, and enhance manufacturing efficiency. Headquartered in South San Francisco, California, with a commercial-scale facility in Bridgewater, New Jersey, Cellares is supported by leading investors and is committed to addressing global patient needs in cell therapy. Their mission emphasizes collaboration, innovation, and a dedication to quality in the life sciences sector.